NFKB1 and type 2 diabetes mellitus: Importantly, we demonstrate that Au/CeO2 0.82% are biocompatible, and modulate these actions, thus decreasing ROS production and NF-κB, which endorses the beneficial effects of this compound in preventing cardiovascular diseases in T2D.